Inventor · disambiguated record
Sarah L. Pogue
Also filed as: POGUE SARAH · POGUE SARAH L · POGUE SARAH LEE
18 granted patents·2 pending applications·174 citations·filing 2004–2022
94Inventor score
Files withTEVA PHARMACEUTICALS AUSTRALIA PTY LTD10TERRETT JONATHAN A3BRISTOL MYERS SQUIBB CO2MEDAREX INC2CARDARELLI JOSEPHINE M1
Top patents by PatentIndex Score
20 records- 0197US8268970B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2008·Granted Sep 18, 2012·65 cites·7 claims
- 0294US8399623B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Mar 19, 2013·25 cites·7 claims
- 0391US10232041B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Mar 19, 2019·9 cites·21 claims
- 0491US8383779B2Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 26, 2013·12 cites·7 claims
- 0590US9636334B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2015·Granted May 2, 2017·9 cites·20 claims
- 0688US8425904B2Human antibodies that bind mesothelin, and uses thereofTERRETT JONATHAN A·Filed 2012·Granted Apr 23, 2013·9 cites·17 claims
- 0787US9963515B2Anti-CD38 antibodies and fusions to attenuated interferon alpha-2BTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2015·Granted May 8, 2018·5 cites·27 claims
- 0887US9611322B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2014·Granted Apr 4, 2017·6 cites·18 claims
- 0986US12258401B2Anti-CD47 combination therapyTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2022·Granted Mar 25, 2025·1 cites·21 claims
- 1084US8496931B2Monoclonal antibodies against stromal derived factor-1 (SDF-1)POGUE SARAH L·Filed 2007·Granted Jul 30, 2013·13 cites·38 claims
- 1183US10981986B2Fusions of antibodies to CD38 and attenuated interferon alphaTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Apr 20, 2021·2 cites·21 claims
- 1280US9932411B2AntibodiesOXFORD BIOTHERAPEUTICS LTD·Filed 2014·Granted Apr 3, 2018·5 cites·24 claims
- 1378US7888484B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)MEDAREX INC·Filed 2009·Granted Feb 15, 2011·2 cites·5 claims
- 1478US7619070B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)MEDAREX INC·Filed 2004·Granted Nov 17, 2009·8 cites·17 claims
- 1575US11117975B2Anti-CD38 antibodies and fusions to attenuated interferon alpha-2BTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2018·Granted Sep 14, 2021·1 cites·13 claims
- 1673US11618784B2Anti-CD47 combination therapyTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2017·Granted Apr 4, 2023·1 cites·21 claims
- 1771US11253591B2Combination of lenalidomide and polypeptide construct, and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2019·Granted Feb 22, 2022·0 cites·17 claims
- 1870US8758757B2Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)CARDARELLI JOSEPHINE M·Filed 2010·Granted Jun 24, 2014·1 cites·16 claims
- 1960US2013190481A1Human antibodies that bind mesothelin, and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2054US2016367695A1Polypeptide constructs and uses thereofTEVA PHARMACEUTICALS AUSTRALIA PTY LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →